Latest news

Thumbnail image for EU approves new option for metastatic melanoma

EU approves new option for metastatic melanoma

The European Commission (EC) has granted marketing authorisation for Pierre Fabre’s Braftovi and Mektovi combination therapy for the treatment of adults with unresectable or metastatic melanoma with a BRAFV600 mutation.

24th September 2018

Thumbnail image for CHMP puts 13 therapies forward for EU approval

CHMP puts 13 therapies forward for EU approval

Marking a bumper month for Committee for Medicinal Products for Human Use (CHMP) decisions, 13 medicines have been put forward for approval in the region, including three orphan medicines.

24th September 2018

Thumbnail image for Medical & Scientific Excellence Awards - Have you entered yet?

Medical & Scientific Excellence Awards - Have you entered yet?

New from PharmaTimes Media is the Medical & Scientific Excellence Awards.Highlighting this important area of work within the pharmaceutical industry, the awards are designed to recognise the outstanding achievements of medical and scientific professionals.

21st September 2018

Thumbnail image for ABPI enters five-year partnership with AHSN

ABPI enters five-year partnership with AHSN

The Association of the British Pharmaceutical Industry (ABPI) is linking arms with the Academic Health Science Network in a five-year partnership that strives to accelerate uptake of transformative biomedical innovations by the NHS

21st September 2018

Thumbnail image for Daiichi to test cancer drug combo

Daiichi to test cancer drug combo

Daiichi Sankyo has entered into a clinical trial collaboration agreement with a subsidiary of MSD to evaluate a potential new combination therapy for breast or lung cancers.

21st September 2018

Thumbnail image for CR UK forms £30m partnership with EU cancer charities

CR UK forms £30m partnership with EU cancer charities

Cancer Research UK is partnering with European cancer research charities AIRC (Associazione Italiana per la Ricerca sul Cancro) and FC AECC (Asociación Española Contra el Cáncer) to invest around £30 million in six international collaborations aiming to accelerate progress in translational research.

20th September 2018

Previous  --   1 2 3 4 5 6 7 8 9 10   --  Next

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download